Diane Ruffcorn
New Here
Exactly - and that information is what led me to Neumeister in the first place.Yes - I understand that it was meant to somehow mimic the effects of a cannabinoid...or somehow addr...
The first trial I participated in was a brain imaging study, a collaborative effort of NYU and Yale. However, they weren't imaging anything related to the endocannabinoid system - it was studying Kappa Opioid Receptors. Based on the results of those scans I was invited back to participate in two drug trials. The second trial (mGlu) was targeting KOR.
All three studies were cancelled and all the data was shit-canned. So unbelievably disappointing. :(